Intelligent Bio Solutions Inc. has announced amendments to the employment agreements of its President and CEO, Harry Simeondis, and CFO, Spiro Sakiris, effective June 30, 2025. Key changes include a tiered non-compete period ranging from 24 to 1 month post-employment, expanded non-compete restrictions, and enhanced severance benefits. In case of termination without cause, employees will receive a cash payment equal to 100% of their potential bonus and immediate full vesting of equity awards. If termination occurs due to a Change in Control, they will also receive two times their annual base salary and an additional bonus payment. Additionally, the Board has approved salary increases, with Mr. Simeondis's salary rising to AUD$580,000 and Mr. Sakiris's to AUD$430,000.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.